These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20861311)

  • 21. Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.
    Konda N; Saeki N; Nishino S; Ogawa K
    Histochem Cell Biol; 2017 Mar; 147(3):317-339. PubMed ID: 27665280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling.
    Nasreen N; Khodayari N; Sriram PS; Patel J; Mohammed KA
    Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1154-66. PubMed ID: 24717580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
    Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
    Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
    Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts.
    Miura K; Nam JM; Kojima C; Mochizuki N; Sabe H
    Mol Biol Cell; 2009 Apr; 20(7):1949-59. PubMed ID: 19193766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.
    Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB
    Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratinocyte apoptosis on type I collagen fibrils is prevented by Erk1/2 activation under high calcium condition.
    Fujisaki H; Ebihara T; Irie S; Kobayashi T; Adachi E; Mochitate K; Hattori S
    Connect Tissue Res; 2007; 48(3):159-69. PubMed ID: 17522999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A conditional feedback loop regulates Ras activity through EphA2.
    Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F
    Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J; Debinski W
    Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
    J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
    Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
    Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions.
    Perez White BE; Ventrella R; Kaplan N; Cable CJ; Thomas PM; Getsios S
    J Cell Sci; 2017 Jan; 130(1):111-118. PubMed ID: 27815408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.
    Harmon RM; Simpson CL; Johnson JL; Koetsier JL; Dubash AD; Najor NA; Sarig O; Sprecher E; Green KJ
    J Clin Invest; 2013 Apr; 123(4):1556-70. PubMed ID: 23524970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells.
    Allocca C; Cirafici AM; Laukkanen MO; Castellone MD
    Thyroid; 2021 Jan; 31(1):76-87. PubMed ID: 32762307
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury.
    Kim A; Seong KM; Choi YY; Shim S; Park S; Lee SS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
    Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
    Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
    Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.